FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:KITLG-CCDC6

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: KITLG-CCDC6
FusionPDB ID: 42800
FusionGDB2.0 ID: 42800
HgeneTgene
Gene symbol

KITLG

CCDC6

Gene ID

4254

8030

Gene nameKIT ligandcoiled-coil domain containing 6
SynonymsDCUA|DFNA69|FPH2|FPHH|KL-1|Kitl|MGF|SCF|SF|SHEP7|SLFD10S170|H4|PTC|TPC|TST1
Cytomap

12q21.32

10q21.2

Type of geneprotein-codingprotein-coding
Descriptionkit ligandc-Kit ligandfamilial progressive hyperpigmentation 2mast cell growth factorsteel factorstem cell factorcoiled-coil domain-containing protein 6papillary thyroid carcinoma-encoded protein
Modification date2020032020200327
UniProtAcc

P21583

Main function of 5'-partner protein: FUNCTION: Ligand for the receptor-type protein-tyrosine kinase KIT. Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KITLG/SCF binding can activate several signaling pathways. Promotes phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and subsequent activation of the kinase AKT1. KITLG/SCF and KIT also transmit signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. KITLG/SCF and KIT promote activation of STAT family members STAT1, STAT3 and STAT5. KITLG/SCF and KIT promote activation of PLCG1, leading to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KITLG/SCF acts synergistically with other cytokines, probably interleukins.

A6NI79

Main function of 5'-partner protein: FUNCTION: May act as a scaffold to regulate the recruitment and assembly of spindle midzone components. Required for the localization of AURKB and PLK1 to the spindle midzone. {ECO:0000305|PubMed:20962590}.
Ensembl transtripts involved in fusion geneENST idsENST00000357116, ENST00000228280, 
ENST00000347404, ENST00000378535, 
ENST00000263102, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score6 X 4 X 3=7212 X 8 X 6=576
# samples 714
** MAII scorelog2(7/72*10)=-0.0406419844973459
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(14/576*10)=-2.04064198449735
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: KITLG [Title/Abstract] AND CCDC6 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: KITLG [Title/Abstract] AND CCDC6 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)KITLG(88974041)-CCDC6(61612460), # samples:2
Anticipated loss of major functional domain due to fusion event.KITLG-CCDC6 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KITLG-CCDC6 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KITLG-CCDC6 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
KITLG-CCDC6 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneKITLG

GO:0008284

positive regulation of cell proliferation

9722506

HgeneKITLG

GO:0035162

embryonic hemopoiesis

21149635



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:88974041/chr10:61612460)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across KITLG (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across CCDC6 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000228280KITLGchr1288974041-ENST00000263102CCDC6chr1061612460-54741981531319388
ENST00000347404KITLGchr1288974041-ENST00000263102CCDC6chr1061612460-58645885431709388

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000228280ENST00000263102KITLGchr1288974041-CCDC6chr1061612460-0.0010471920.99895275
ENST00000347404ENST00000263102KITLGchr1288974041-CCDC6chr1061612460-0.0012264260.9987735

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for KITLG-CCDC6

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
KITLGchr1288974041CCDC6chr106161246019814CWIAALPFLMKKTQQARAEQEEEFIS
KITLGchr1288974041CCDC6chr106161246058814CWIAALPFLMKKTQQARAEQEEEFIS

Top

Potential FusionNeoAntigen Information of KITLG-CCDC6 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KITLG-CCDC6_88974041_61612460.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KITLG-CCDC6chr1288974041chr1061612460198HLA-B08:09LMKKTQQA0.99040.7847816
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:22FLMKKTQQA0.98730.754716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:11FLMKKTQQA0.98470.5829716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:60FLMKKTQQA0.98420.6047716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:24FLMKKTQQA0.98340.5491716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:30FLMKKTQQA0.98340.5491716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:67FLMKKTQQA0.98340.5491716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:27FLMKKTQQA0.98190.5849716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:13FLMKKTQQA0.98010.6643716
KITLG-CCDC6chr1288974041chr1061612460198HLA-B08:09FLMKKTQQA0.97910.8195716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:16FLMKKTQQA0.97710.5423716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:21FLMKKTQQA0.97640.6609716
KITLG-CCDC6chr1288974041chr1061612460198HLA-B08:01FLMKKTQQA0.97460.791716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:38FLMKKTQQA0.95550.6071716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:19FLMKKTQQA0.94930.5375716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:04FLMKKTQQA0.94310.8453716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:29FLMKKTQQA0.92960.5514716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:35FLMKKTQQA0.91510.575716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:17FLMKKTQQA0.89290.6457716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:20FLMKKTQQA0.88910.5625716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A31:02LMKKTQQAR0.87710.6406817
KITLG-CCDC6chr1288974041chr1061612460198HLA-B08:09LPFLMKKTQQA0.9730.8469516
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:13FLMKKTQQARA0.93160.7009718
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:02FLMKKTQQA0.98690.7276716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:07FLMKKTQQA0.98360.6307716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:01FLMKKTQQA0.98340.5491716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:05FLMKKTQQA0.98180.8129716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A31:01LMKKTQQAR0.94120.597817
KITLG-CCDC6chr1288974041chr1061612460198HLA-B15:04FLMKKTQQA0.44660.9458716
KITLG-CCDC6chr1288974041chr1061612460198HLA-B54:01LPFLMKKTQQA0.99630.5722516
KITLG-CCDC6chr1288974041chr1061612460198HLA-B78:01LPFLMKKTQQA0.9080.723516
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:03FLMKKTQQA0.99220.7564716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:06FLMKKTQQA0.97640.6609716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:14FLMKKTQQA0.97610.658716
KITLG-CCDC6chr1288974041chr1061612460198HLA-B08:18FLMKKTQQA0.97460.791716
KITLG-CCDC6chr1288974041chr1061612460198HLA-B08:12FLMKKTQQA0.64320.8987716
KITLG-CCDC6chr1288974041chr1061612460198HLA-C07:04FLMKKTQQA0.08770.949716
KITLG-CCDC6chr1288974041chr1061612460198HLA-A02:03FLMKKTQQARA0.9820.8091718
KITLG-CCDC6chr1288974041chr1061612460198HLA-B78:02LPFLMKKTQQA0.8990.7315516

Top

Potential FusionNeoAntigen Information of KITLG-CCDC6 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KITLG-CCDC6_88974041_61612460.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0103ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0103AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0103LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0447ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0454ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0454AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0802ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0802AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0802LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0802IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0803ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0807ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0807AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0808ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0808AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0809ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0809AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0809LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0809IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0811ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0811AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0813ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0813AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0813LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0813IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0814ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0815ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0815AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0815LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0815IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0821ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0821AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0821LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0821IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0823ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0824ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0824AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0827ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0830ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0830AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0830LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0830IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0832ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0833ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0835ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0836ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0837ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0837AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-0838ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1105ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1105AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1111ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1111AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1114ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1120ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1127ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1130ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1130AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1130LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1130IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1132ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1132AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1137ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1145ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1145AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1145LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1145IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1164ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1164AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1164LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1168ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1169ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1169AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1172ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1172AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1182ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1186ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1302ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1307ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1316ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1323ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1326ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1326AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1329ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1334ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1336ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1336AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1339ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1347ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1347AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1347LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1347IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1363ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1363AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1367ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1367AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1367LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1367IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1373ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1374ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1385ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1396ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1397ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1399ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1402ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1403ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1403AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1403LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1403IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1424ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1424AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1427ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1427AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1427LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1427IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1440ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1440AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1440LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1440IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1441ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1446ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1463ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1463AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1467ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1467AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1467LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1467IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1477ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1477AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1477LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1477IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1485ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1485AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1489ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1489AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1489LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1494ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1498ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1498AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1498LPFLMKKTQQARAEQ520
KITLG-CCDC6chr1288974041chr1061612460198DRB1-1498IAALPFLMKKTQQAR217
KITLG-CCDC6chr1288974041chr1061612460198DRB5-0102ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB5-0103ALPFLMKKTQQARAE419
KITLG-CCDC6chr1288974041chr1061612460198DRB5-0103AALPFLMKKTQQARA318
KITLG-CCDC6chr1288974041chr1061612460198DRB5-0108NALPFLMKKTQQARAE419

Top

Fusion breakpoint peptide structures of KITLG-CCDC6

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6617PFLMKKTQQARAEQKITLGCCDC6chr1288974041chr1061612460198

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of KITLG-CCDC6

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN6617PFLMKKTQQARAEQ-7.15543-7.26883
HLA-B14:023BVN6617PFLMKKTQQARAEQ-4.77435-5.80965
HLA-B52:013W396617PFLMKKTQQARAEQ-6.80875-6.92215
HLA-B52:013W396617PFLMKKTQQARAEQ-4.20386-5.23916
HLA-A11:014UQ26617PFLMKKTQQARAEQ-7.5194-8.5547
HLA-A11:014UQ26617PFLMKKTQQARAEQ-6.9601-7.0735
HLA-A24:025HGA6617PFLMKKTQQARAEQ-7.52403-7.63743
HLA-A24:025HGA6617PFLMKKTQQARAEQ-5.82433-6.85963
HLA-B27:056PYJ6617PFLMKKTQQARAEQ-3.28285-4.31815
HLA-B44:053DX86617PFLMKKTQQARAEQ-5.91172-6.94702
HLA-B44:053DX86617PFLMKKTQQARAEQ-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of KITLG-CCDC6

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
KITLG-CCDC6chr1288974041chr1061612460516LPFLMKKTQQACCTTTCCTTATGAAGAAGACACAACAAGCCAGG
KITLG-CCDC6chr1288974041chr1061612460716FLMKKTQQACTTATGAAGAAGACACAACAAGCCAGG
KITLG-CCDC6chr1288974041chr1061612460718FLMKKTQQARACTTATGAAGAAGACACAACAAGCCAGGGCTGAG
KITLG-CCDC6chr1288974041chr1061612460816LMKKTQQAATGAAGAAGACACAACAAGCCAGG
KITLG-CCDC6chr1288974041chr1061612460817LMKKTQQARATGAAGAAGACACAACAAGCCAGGGCT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
KITLG-CCDC6chr1288974041chr1061612460217IAALPFLMKKTQQARGCAGCGCTGCCTTTCCTTATGAAGAAGACACAACAAGCCAGGGCT
KITLG-CCDC6chr1288974041chr1061612460318AALPFLMKKTQQARAGCGCTGCCTTTCCTTATGAAGAAGACACAACAAGCCAGGGCTGAG
KITLG-CCDC6chr1288974041chr1061612460419ALPFLMKKTQQARAECTGCCTTTCCTTATGAAGAAGACACAACAAGCCAGGGCTGAGCAG
KITLG-CCDC6chr1288974041chr1061612460520LPFLMKKTQQARAEQCCTTTCCTTATGAAGAAGACACAACAAGCCAGGGCTGAGCAGGAA

Top

Information of the samples that have these potential fusion neoantigens of KITLG-CCDC6

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
LUSCKITLG-CCDC6chr1288974041ENST00000228280chr1061612460ENST00000263102TCGA-22-1017-01A

Top

Potential target of CAR-T therapy development for KITLG-CCDC6

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to KITLG-CCDC6

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to KITLG-CCDC6

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgeneCCDC6C0238463Papillary thyroid carcinoma2CTD_human;ORPHANET
TgeneCCDC6C3501843Nonmedullary Thyroid Carcinoma1CTD_human
TgeneCCDC6C3501844Familial Nonmedullary Thyroid Cancer1CTD_human